2025-03-05 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Report

**0. Overview:** Colgate-Palmolive Co (CL) is a leading consumer goods company specializing in oral hygiene, personal care, and household products.


**1. Performance Comparison and Divergence:**

Colgate-Palmolive (CL) has shown a cumulative return of 39.32% compared to the S&P 500 (VOO) which has returned 108.99%.  This results in a significant lag of -69.7%.  The relative divergence of -20.7% indicates that CL's performance sits in the lower 20.7% percentile of its historical performance range relative to the S&P 500, based on the provided min/max range.  The Alpha and Beta values in the provided table suggest varying levels of performance relative to the market (Beta), with Alpha suggesting periods of outperformance and underperformance. Note that this alpha and beta analysis is based on limited data points and doesn't represent a comprehensive market assessment.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 13.0% | 4.6% | -15.0% | 0.1 | 51.5 |
| 2016-2018  | -12.0% | 8.5% | -30.0% | 0.3 | 41.6 |
| 2017-2019  | 9.0% | 8.5% | -21.0% | 0.2 | 49.4 |
| 2018-2020  | 21.0% | 8.5% | -6.0% | 0.7 | 62.8 |
| 2019-2021  | 32.0% | 7.3% | -39.0% | 1.0 | 64.1 |
| 2020-2022  | 7.0% | 9.3% | -2.0% | 1.0 | 60.6 |
| 2021-2023  | 3.0% | 9.3% | -20.0% | 1.0 | 62.9 |
| 2022-2024  | 13.0% | 9.3% | -20.0% | 1.0 | 73.4 |
| 2023-2025  | 24.0% | 8.8% | 0.5 | 73.9 |


**2. Recent Price Movement:**

* **Closing Price:** $91.06
* **5-Day Moving Average:** $91.08
* **20-Day Moving Average:** $88.42
* **60-Day Moving Average:** $89.57

The price is slightly below the 5-day moving average, suggesting recent consolidation or a minor downward trend.  It's above both the 20-day and 60-day moving averages, hinting at potential support levels. The closing price shows a decline of -$1.88 from the previous close.


**3. Technical Indicators and Expected Return:**

* **RSI:** 61.44 (Slightly above neutral; not overbought)
* **PPO:** 0.59 (Positive, indicating bullish momentum)
* **20-Day Relative Divergence Change:** +5.1% (Short-term upward trend)
* **Expected Return:** -171.5% (This extremely negative expected return relative to the S&P 500 needs further clarification as to the methodology used for this calculation. It is highly unusual and warrants further investigation).  The large negative change from the previous closing price (-$1.88) shows a recent drop.


**4. Recent Earnings Analysis:**

The provided earnings data shows relatively stable revenue around $5 Billion, with EPS showing minor fluctuations.  There is a slight downward trend in recent EPS. More context such as industry comparisons is needed for a fuller analysis.

| Date       | EPS | Revenue    |
|------------|-----|------------|
| 2024-10-25 | 0.9 | $5.03 B    |
| 2024-07-26 | 0.89 | $5.06 B    |
| 2024-04-26 | 0.83 | $5.07 B    |
| 2023-10-27 | 0.86 | $4.92 B    |
| 2024-10-25 | 0.86 | $4.92 B    | *(Duplicate entry?)*


**5. Financial Information:**

The financial data shows strong revenue and relatively stable profit margins.  However, the ROE figures are exceptionally high and volatile, requiring further scrutiny to understand the underlying drivers.  Extremely high ROE values such as 594.31% and 348.58% are unusual and may indicate accounting issues or unusual circumstances requiring further investigation.

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $4.95B | 60.30%       |
| 2024-09-30 | $5.03B | 61.08%       |
| 2024-06-30 | $5.06B | 60.62%       |
| 2024-03-31 | $5.07B | 60.00%       |
| 2023-12-31 | $4.95B | 59.60%       |


**Capital and Profitability:**

| Quarter | Equity | ROE          |
|---------|---------|---------------|
| 2024-12-31 | $0.21B | 348.58%      |
| 2024-09-30 | $0.43B | 169.43%      |
| 2024-06-30 | $0.12B | 594.31%      |
| 2024-03-31 | $0.23B | 296.96%      |
| 2023-12-31 | $0.61B | 117.90%      |


**6.  Overall Analysis:**

Colgate-Palmolive shows relatively stable revenue and profit margins but lags significantly behind the S&P 500 in terms of cumulative returns. The provided alpha and beta values suggest periods of both outperformance and underperformance relative to the market.  Technical indicators suggest a neutral to slightly bullish short-term outlook, although the recent price drop warrants attention.  The highly volatile and unusually high ROE values require further investigation to ensure data accuracy and understanding of the underlying drivers.  The extremely negative expected return calculation (-171.5%) needs clarification and validation. A deeper dive into the company's financials and industry comparisons is necessary for a comprehensive assessment.  The duplicate data entry in the earnings report also needs clarification.
